190 related articles for article (PubMed ID: 26085373)
21. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
22. Phospholipase D2 downregulation induces cellular senescence through a reactive oxygen species-p53-p21Cip1/WAF1 pathway.
Lee YH; Bae YS
FEBS Lett; 2014 Aug; 588(17):3251-8. PubMed ID: 25064843
[TBL] [Abstract][Full Text] [Related]
23. Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance.
D'Amore C; Borgo C; Sarno S; Salvi M
Cell Oncol (Dordr); 2020 Dec; 43(6):1003-1016. PubMed ID: 33052585
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
[TBL] [Abstract][Full Text] [Related]
25. CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
Dixit D; Ahmad F; Ghildiyal R; Joshi SD; Sen E
Exp Cell Res; 2016 May; 344(1):132-142. PubMed ID: 27001465
[TBL] [Abstract][Full Text] [Related]
26. CK2 downregulation induces senescence-associated heterochromatic foci formation through activating SUV39h1 and inactivating G9a.
Park JW; Kim JJ; Bae YS
Biochem Biophys Res Commun; 2018 Oct; 505(1):67-73. PubMed ID: 30241941
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock.
Kang NI; Yoon HY; Kim HA; Kim KJ; Han MK; Lee YR; Hwang PH; Soh BY; Shin SJ; Im SY; Lee HK
J Immunol; 2011 Jun; 186(11):6625-32. PubMed ID: 21531890
[TBL] [Abstract][Full Text] [Related]
28. PML promotes senescence via JAK/STAT signaling.
Krämer A
Cell Cycle; 2010 Aug; 9(15):2931. PubMed ID: 20703079
[No Abstract] [Full Text] [Related]
29. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
[TBL] [Abstract][Full Text] [Related]
30.
Parisotto M; Grelet E; El Bizri R; Dai Y; Terzic J; Eckert D; Gargowitsch L; Bornert JM; Metzger D
J Exp Med; 2018 Jun; 215(6):1749-1763. PubMed ID: 29743291
[TBL] [Abstract][Full Text] [Related]
31. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.
Quotti Tubi L; Canovas Nunes S; Brancalion A; Doriguzzi Breatta E; Manni S; Mandato E; Zaffino F; Macaccaro P; Carrino M; Gianesin K; Trentin L; Binotto G; Zambello R; Semenzato G; Gurrieri C; Piazza F
Leukemia; 2017 Feb; 31(2):292-300. PubMed ID: 27479180
[TBL] [Abstract][Full Text] [Related]
33. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
34. NLK is a novel therapeutic target for PTEN deficient tumour cells.
Mendes-Pereira AM; Lord CJ; Ashworth A
PLoS One; 2012; 7(10):e47249. PubMed ID: 23144700
[TBL] [Abstract][Full Text] [Related]
35. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
[TBL] [Abstract][Full Text] [Related]
36. Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies.
Gowda C; Sachdev M; Muthusami S; Kapadia M; Petrovic-Dovat L; Hartman M; Ding Y; Song C; Payne JL; Tan BH; Dovat S
Curr Pharm Des; 2017; 23(1):95-107. PubMed ID: 27719640
[TBL] [Abstract][Full Text] [Related]
37. CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation.
Lin YC; Hung MS; Lin CK; Li JM; Lee KD; Li YC; Chen MF; Chen JK; Yang CT
Cancer Biother Radiopharm; 2011 Jun; 26(3):381-8. PubMed ID: 21711111
[TBL] [Abstract][Full Text] [Related]
38. PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2.
Patsoukis N; Li L; Sari D; Petkova V; Boussiotis VA
Mol Cell Biol; 2013 Aug; 33(16):3091-8. PubMed ID: 23732914
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
40. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells.
Kim KY; Lee JH; Park JH; Yoo MA; Kwak YG; Kim SO; Yoo SE; Hong KW
Eur J Pharmacol; 2004 Aug; 497(3):267-77. PubMed ID: 15336944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]